An external use agent for treating chronic rhinitis and nasosinusitis

Abstract

This invention provides an external use medincet for treating chronic rhinitis and nasosinusitis. It is prepared by using the following Chinese medical ingredients according to their weight ratio: American ginseng 15-3, peony root bark 12-5,Chinese angelica root 12-5,towelgourd vascular bundles 10-5,balloon-flower 10-5,puncturevine caltrap fruit 10-5, coptis rhizome0-5,membranous milkvetch root 10-5,ginseng 10-5,sevenlobed yam rhizome 8-5,pumice8-5,fructus forsythiae 8-5,Dahurian angelica root 5-1,biond magnolia flower-bud 5-1,skebia stem 5-1,siberian cocklebur fruit 5-1,cassiabarktree bark 3-1,manchurian whildginger herb 3-1.In the aspect of the medical application, it is convenient and easy to use with light side effects, no irritatations to the skin and obvious curative effects. According to statistics that the total effective ratio for treating chronic rhinitis, chronic nasosinusitis is above 95%.

Description

Technical field:

[0001] The invention belongs to a Chinese patent medicine, in particular to an external medicine for treating chronic rhinitis and chronic sinusitis prepared by using traditional Chinese medicine. Background technique:

[0002] Western medicine believes that chronic rhinitis and chronic sinusitis are mostly chronic inflammations of nasal mucosa and submucosal tissue hypertrophy, hyperplasia, and mucosal edema. Often due to the lack of timely treatment or improper and incomplete treatment in the acute phase, it leads to persistent chronic inflammation: (1) Acute rhinitis recurs, and the deep blood vessels of the nasal mucosa dilate, especially the cavernous sinus of the inferior turbinate, which leads to swelling of the turbinate; mucus glands are active and secrete more; inflammatory cells infiltrate around the blood vessels and glands; in simple rhinitis On the basis of the disease, the lesion continues to develop, causing fibrous tissue hyperplasia, leadin...